Edwards Lifesciences Accounts Payable

Edwards Lifesciences (EW) currently reports a accounts payable of $180M as of March 2026. That compares with $170M in the prior-year period — up 5.0% year over year. Use the charts on this page to explore Edwards Lifesciences's accounts payable history and peer comparisons.

Edwards Lifesciences's accounts payable increased from $170M to $180M — a 5.0% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Edwards Lifesciences reported $180M in accounts payable as of March 2026. That compares with $170M in the prior-year period — up 5.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $180M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Edwards Lifesciences, and consider following EW for alerts when major investors trade the stock.

Edwards Lifesciences is classified in the Healthcare sector. On accounts payable, it currently shows $180M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EW with unrelated industries.